Korean Drug Co. Ltd Capital Reinvestment Ratio
Korean Drug Co. Ltd capital reinvestment ratio. Korean Drug Co. Ltd (014570) has a Capital Reinvestment Ratio of 0.01x as of June 2026, meaning it reinvests 0% of its operating cash flow (₩1.90 Billion) in capital expenditures (₩17.20 Million). Check Korean Drug Co. Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Korean Drug Co. Ltd (2014–2025)
Capital reinvestment ratio of Korean Drug Co. Ltd from 2014 to 2025. This chart tracks Korean Drug Co. Ltd's Capital Reinvestment Ratio across 11 annual periods. Also explore Korean Drug Co. Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Korean Drug Co. Ltd Capital Reinvestment Ratio by Year (2014–2025)
Korean Drug Co. Ltd capital reinvestment ratio by year from 2014 to 2025. For the full cash flow conversion analysis, see Korean Drug Co. Ltd operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | ₩13.11 Billion | ₩475.05 Million | ▼ -83.1% |
| 2024 | 0.21x | ₩4.87 Billion | ₩1.04 Billion | ▼ -79.2% |
| 2022 | 1.03x | ₩5.91 Billion | ₩6.09 Billion | ▲ +691.9% |
| 2021 | 0.13x | ₩8.81 Billion | ₩1.15 Billion | ▲ +117.3% |
| 2020 | 0.06x | ₩12.33 Billion | ₩738.47 Million | ▼ -87.8% |
| 2019 | 0.49x | ₩6.21 Billion | ₩3.05 Billion | ▲ +118.8% |
| 2018 | 0.22x | ₩5.79 Billion | ₩1.30 Billion | ▼ -91.1% |
| 2017 | 2.53x | ₩447.20 Million | ₩1.13 Billion | ▲ +2077.4% |
| 2016 | 0.12x | ₩3.96 Billion | ₩460.84 Million | ▼ -18.8% |
| 2015 | 0.14x | ₩6.13 Billion | ₩878.05 Million | ▲ +18.7% |
| 2014 | 0.12x | ₩4.46 Billion | ₩538.19 Million | — |